Microbiome Metabolite Mimics Accelerate Drug Discovery

Area of Science:

• Pharmacology
• Drug Discovery
• Microbiology

Background:

• The human pregnane X receptor (hPXR) plays a role in xenobiotic metabolism and inflammation.
• Microbial catabolism of tryptophan produces various metabolites with potential biological activity.

Purpose of the Study:

• To explore metabolite mimicry as a drug development strategy.
• To design and validate a potent hPXR agonist derived from microbial tryptophan metabolites.

Main Methods:

• Design of a novel hPXR agonist based on tryptophan-derived ligands.
• In vitro validation using cellular assays.
• In vivo testing in a murine colitis model expressing hPXR.

Main Results:

• A potent agonist of hPXR was successfully synthesized.
• The synthesized compound demonstrated efficacy in reducing inflammation biomarkers in cellular assays.
• Significant reduction in inflammation was observed in the murine colitis model.

Conclusions:

• Metabolite mimicry is a promising strategy for developing novel therapeutics.
• The designed hPXR agonist shows potential for treating inflammatory conditions like colitis.